Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)

The National Institutes of Health, through the National Institute of Neurological Disorders and Stroke, is issuing a forecast for a U24 grant to investigate novel therapeutic interventions and testing strategies for neurological disorders, with a specific focus on treating, modifying, and preventing epilepsy. The initiative seeks research encompassing various intervention modalities and the development and validation of human-focused testing approaches. This opportunity is targeted toward investigators with expertise in preclinical therapy testing and model development. While clinical trials are not allowed under this specific solicitation, the goal is to advance the strategies used to evaluate new treatments for neurological conditions. Interested parties can contact Brian Klein at the National Institutes of Health for further information.